Article
Epigenome editing of human hematopoietic stem cells enables sustained and reversible thrombosis prevention
2026-03-29
Abstract excerpt
Thrombosis remains a major cause of cardiovascular and cerebrovascular diseases, driven in large part by platelet activation and aggregation. Because platelets are continuously produced from hematopoietic stem cells (HSCs), durable reprogramming of HSC output offers a unique opportunity for a one-time antithrombotic intervention. Here, we show that DNA methylation-based epigenome editors delivered transiently as R...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 314dd4de-dd13-57a7-8a4d-7fd66f8c3e70
- DOI
- 10.64898/2026.03.27.714536
